3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
2
Tumor-Agnostic
1
Sarcoma
1
Other
1
Dermatologic
1
Conditions
Surgical Wound Infection
1
Skin Neoplasms
1
Postoperative Complications
1
Interventions
pembrolizumab
161
Nivolumab
133
Ipilimumab
78
Cyclophosphamide
47
Specimen Handling
43
Magnetic Resonance Spectroscopy
39
cemiplimab
35
Biopsy
31
fludarabine
29
trametinib
24
relatlimab
24
binimetinib
23
Interleukin-2
22
fludarabine phosphate
21
dabrafenib
20
atezolizumab
19
Radiotherapy
19
Opdualag
19
aldesleukin
18
Radiosurgery
18
CTLA-4 Antigen
18
encorafenib
17
Blood Specimen Collection
17
avelumab
14
Immunoglobulin G
14
Disulfides
13
lifileucel
11
lenvatinib
11
Bevacizumab
11
Paclitaxel
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Negative-Pressure Wound Therapy
×
Dermatologic
×
1 year
×
Clear all
NCT07040683
2026-05-28
LEGS
Region Skane
Phase NA
Recruiting
242 enrolled